Artificial Intelligence & Ophthalmology
EVOLUCARE AND ADCIS ANNOUNCE THE CREATION OF OPHTAI, A JOINT VENTURE DEDICATED TO ARTIFICIAL INTELLIGENCE FOR OPHTHALMOLOGY, AT THE NEXT FRENCH OPHTHALMOLOGY SOCIETY CONVENTION On May 12, 2019, Evolucare, a medium-size enterprise largely renowned for its expertise...
Evolucare at the International Congress of the French Ophtalmology Society
Evolucare will participate to the International Congress of the French Ophtalmology Society, from 11 to 14 May. During this event, in collaboration with our partner ADCIS, we will present our new AI solution : OphtAI. Come and meet us for a demo at booth M11 !
#OphtAI gets CE Medical Device Certification
#OphtAI, the new #AI product line of #Evolucare and #ADCIS, gets CE Medical Device Certification. Our Artificial Intelligence, now available for clinical use, identifies diabetic retinopathy from a mere retina fundus image with performances on par with the best retina...
Signature of a global and exclusive licence agreement for the exploitation of OphtAI
At CES 2019, Evolucare, associated with ADCIS, enters into a global and exclusive license agreement with SATT Ouest Valorisation, a French technology transfer office, and AP-HP Paris hospitals for the exploitation of OphtAI